| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 714379 | Null | 0.00970780973624031 | 0.31706093 |
| NSC 719715 | Null | 0.00970780973624031 | 0.20090269 |
| NSC 720447 | Null | 0.00970780973624031 | -0.33337974 |
| NSC 726267 | Null | 0.00970780973624031 | -0.094205318 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.00970780973624031 | 0.2429776 |
| NSC 737231 | Null | 0.00970780973624031 | 0.15377117 |
| NSC 740 | Methotrexate | 0.00970780973624031 | 0.31287572 |
| NSC 743528 | Null | 0.00970780973624031 | 0.47848259 |
| NSC 747461 | Null | 0.00970780973624031 | -0.13517806 |
| NSC 763059 | Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride | 0.00970780973624031 | 0.39712105 |